Formulation and pharmacology of long-acting cabotegravir-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Formulation and pharmacology of long-acting cabotegravir

Published:2015-07 Issue:4 Volume:10 Page:239-245
ISSN:1746-630X
Container-title:Current Opinion in HIV and AIDS
language:en
Short-container-title:Current Opinion in HIV and AIDS

Author:

Trezza Christine,Ford Susan L.,Spreen William,Pan Rennan,Piscitelli Stephen

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Virology,Infectious Diseases,Oncology(nursing),Oncology,Hematology,Immunology

Reference14 articles.

1. Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection

2. Prevention of HIV-1 Infection with Early Antiretroviral Therapy

3. The long-acting integrase inhibitor GSK744 protects macaques from repeated intravaginal SHIV challenge

4. A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge

5. Long-Acting Integrase Inhibitor Protects Macaques from Intrarectal Simian/Human Immunodeficiency Virus

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A selective, sensitive and fast LC–MS/MS method for cabotegravir quantification in rat plasma and pharmacokinetic investigations;Biomedical Chromatography;2024-09-09

2. Antiretroviral (ARV) Properties Dictate Long-Acting Release and Tissue Partitioning Behaviors in Multidrug Subcutaneous Implants;ACS Biomaterials Science & Engineering;2024-09-04

3. Current status of the small molecule anti-HIV drugs in the pipeline or recently approved;Bioorganic & Medicinal Chemistry;2024-09

4. Hazards of antiviral contamination in water: Dissemination, fate, risk and their impact on fish;Journal of Hazardous Materials;2024-09

5. Patient-Centric Long-Acting Injectable and Implantable Platforms─An Industrial Perspective;Molecular Pharmaceutics;2024-08-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3